Health Insurance MarketplaceSM, 11583-11585 [2017-03598]
Download as PDF
Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices
asabaliauskas on DSK3SPTVN1PROD with NOTICES
meetings, subsequent workgroup
reconsiderations, and final decisions,
we are able to consider only those
comments received in writing by the
close of the public meeting at which the
request is discussed.
IV. Security, Building, and Parking
Guidelines
The meetings are held within the
CMS Complex which is not open to the
general public. Visitors to the complex
are required to show a valid
Government issued photo identification
at the time of entry. As of October, 10,
2015, visitors seeking access to federal
agency facilities using their state-issued
driver’s license or identification cards
must present proper identification
issued by a state that is compliant with
the REAL ID Act of 2005 (Pub. L. 109–
13, 119 Statute 302, enacted on May 11,
2005) or a state that has received an
extension. What constitutes proper
identification and whether a driver’s
license is acceptable identification for
accessing a federal facility may vary,
based on which state issued the driver’s
license. For detailed information, please
refer to the Department of Homeland
Security (DHS) Web site at: https://
www.dhs.gov. When planning to visit a
federal facility, visitors who have
further questions about acceptable forms
of identification are encouraged to
contact the facility to determine
acceptable identification.
Visitors will also be subject to a
vehicle security inspection before access
to the complex is granted. Participants
not in possession of a valid
identification or who are in possession
of prohibited items will be denied
access to the complex. Prohibited items
on federal property include but are not
limited to, alcoholic beverages, illegal
narcotics, explosives, firearms or other
dangerous weapons (including pocket
knives), dogs or other animals except
service animals. Once cleared for entry
to the complex participants will be
directed to visitor parking by a security
officer.
To ensure expedited entry into the
building it is recommended that
participants have their government ID
and a copy of their written meeting
registration confirmation readily
available and that they do not bring
large/bulky items into the building.
Participants are reminded that
photography on the CMS complex is
prohibited. We have also been declared
a tobacco free campus and violators are
subject to legal action. In planning
arrival time, we recommend allowing
additional time to clear security.
Individuals who are not registered in
advance will not be permitted to enter
VerDate Sep<11>2014
17:20 Feb 23, 2017
Jkt 241001
the building and will be unable to
attend the meeting. The invited guests
may not enter the building earlier than
45 minutes before the convening of the
meeting each day.
Guest access to the complex is limited
to the meeting area, the main entrance
lobby, and the cafeteria. If a visitor is
found outside of those areas without
proper escort they may be escorted off
of the premises. Also, be mindful that
there will be an opportunity for
everyone to speak and we request that
everyone waits for the appropriate time
to present their product and opinions.
Disruptive behavior will not be tolerated
and may result in removal from the
meetings and escort from the complex.
No visitor is allowed to attach USB
cables, thumb drives or any other
equipment to any CMS information
technology (IT) system or hardware for
any purpose at any time. Additionally,
our staff is prohibited from taking such
actions on behalf of a visitor or utilizing
any removable media provided by a
visitor.
We cannot assume responsibility for
coordinating the receipt, transfer,
transport, storage, set-up, safety, or
timely arrival of any personal
belongings or items used for
demonstration or to support a
presentation. Special arrangements and
approvals are required at least 2 weeks
prior to each public meeting to bring
pieces of equipment or medical devices.
These arrangements need to be made
directly with the CMS’ Public Meeting
Coordinator. It is possible that certain
requests made in advance of the public
meeting could be denied because of
unique safety, security or handling
issues related to the equipment. A
minimum of 2 weeks is required for
approvals and security procedures. Any
request not submitted at least 2 weeks
in advance of the public meeting will be
denied.
Foreign National Visitors are defined
as Non-US Citizens, and non-lawful
permanent residents, non-resident
aliens or non-green-card holders.
Attendees that are foreign nationals
must identify themselves as such, and
provide the following information for
security clearance to the public meeting
coordinator by the date specified in the
DATES section of this notice:
• Building to Visit/Destination.
• Visit start date, start time, end date,
end time.
• Visitor full name.
• Gender.
• Visitor Title.
• Visitor Organization/Employer.
• Citizenship.
• Birth Place (City, Country).
• Date of Birth.
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
11583
• ID Type (Passport or State
Department ID).
• Passport issued by Country.
• ID (passport) Number.
• ID (passport) issue date.
• ID (passport) expiration date.
• Visa Type.
• Visa Number.
• Purpose of Visit.
Dated: February 16, 2017.
Patrick Conway,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. 2017–03557 Filed 2–23–17; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–7044–N]
Health Insurance MarketplaceSM,
Medicare, Medicaid, and Children’s
Health Insurance Programs; Meeting of
the Advisory Panel on Outreach and
Education (APOE), March 22, 2017
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces the
next meeting of the Advisory Panel on
Outreach and Education (APOE) (the
Panel) in accordance with the Federal
Advisory Committee Act. The Panel
advises and makes recommendations to
the Secretary of the U.S. Department of
Health and Human Services (HHS) and
the Administrator of the Centers for
Medicare & Medicaid Services (CMS) on
opportunities to enhance the
effectiveness of consumer education
strategies concerning the Health
Insurance MarketplaceSM,1 Medicare,
Medicaid, and the Children’s Health
Insurance Program (CHIP). This meeting
is open to the public.
DATES: Meeting Date: Wednesday,
March 22, 2017 8:30 a.m. to 4:00 p.m.
eastern daylight time (e.d.t).
Deadline for Meeting Registration,
Presentations, Special Accommodations
and Comments: Wednesday, March 8,
2017, 5:00 p.m., (e.d.t.).
ADDRESSES: Meeting Location: U.S.
Department of Health & Human
Services, Hubert H. Humphrey Building,
200 Independence Avenue SW., Room
505A, Conference Room, Washington,
DC 20201.
Presentations and Written Comments:
Presentations and written comments
SUMMARY:
1 Health Insurance MarketplaceSM and
MarketplaceSM are service marks of the U.S.
Department of Health & Human Services.
E:\FR\FM\24FEN1.SGM
24FEN1
11584
Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices
asabaliauskas on DSK3SPTVN1PROD with NOTICES
should be submitted to: Thomas Dudley,
Designated Federal Official (DFO),
Office of Communications, Centers for
Medicare & Medicaid Services, 7500
Security Boulevard, Mailstop S1–05–06,
Baltimore, MD 21244–1850 or via email
at Thomas.Dudley@cms.hhs.gov.
Registration: The meeting is open to
the public, but attendance is limited to
the space available. Persons wishing to
attend this meeting must register at the
Web site https://www.regonline.com/
apoemar2017meeting or by contacting
the DFO as listed in the FOR FURTHER
INFORMATION CONTACT section of this
notice, by the date listed in the DATES
section of this notice. Individuals
requiring sign language interpretation or
other special accommodations should
contact the DFO at the address listed in
the ADDRESSES section of this notice by
the date listed in the DATES section of
this notice.
FOR FURTHER INFORMATION CONTACT:
Thomas Dudley, Designated Federal
Official, Office of Communications,
CMS, 7500 Security Boulevard, Mail
Stop S1–05–06, Baltimore, MD 21244–
1850, 410–786–1442, email
Thomas.Dudley@cms.hhs.gov.
Additional information about the APOE
is available on the Internet at: https://
www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE.html.
Press inquiries are handled through the
CMS Press Office at (202) 690–6145.
SUPPLEMENTARY INFORMATION:
I. Background
The Advisory Panel for Outreach and
Education (APOE) (the Panel) is
governed by the provisions of Federal
Advisory Committee Act (FACA) (Pub.
L. 92–463), as amended (5 U.S.C.
Appendix 2), which sets forth standards
for the formation and use of federal
advisory committees. The Panel is
authorized by section 1114(f) of the
Social Security Act (42 U.S.C. 1314(f))
and section 222 of the Public Health
Service Act (42 U.S.C. 217a) and sec.
10(a) of Public Law 92–463 (5 U.S.C.
App. 2, sec. 10(a) and 41 CFR 102–3).
The Secretary of the U.S. Department
of Health and Human Services (HHS)
(the Secretary) signed the charter
establishing the Citizen’s Advisory
Panel on Medicare Education 2 (the
predecessor to the APOE) on January 21,
1999 (64 FR 7899, February 17, 1999) to
advise and make recommendations to
the Secretary and the Administrator of
the Centers for Medicare & Medicaid
2 We note that the Citizen’s Advisory Panel on
Medicare Education is also referred to as the
Advisory Panel on Medicare Education (65 FR
4617). The name was updated in the Second
Amended Charter approved on July 24, 2000.
VerDate Sep<11>2014
17:20 Feb 23, 2017
Jkt 241001
Services (CMS) on the effective
implementation of national Medicare
education programs, including with
respect to the Medicare+Choice (M+C)
program added by the Balanced Budget
Act of 1997 (Pub. L. 105–33).
The Medicare Modernization Act of
2003 (MMA) (Pub. L. 108–173)
expanded the existing health plan
options and benefits available under the
M+C program and renamed it the
Medicare Advantage (MA) program. We
have had substantial responsibilities to
provide information to Medicare
beneficiaries about the range of health
plan options available and better tools
to evaluate these options. The
successful MA program implementation
required CMS to consider the views and
policy input from a variety of private
sector constituents and to develop a
broad range of public-private
partnerships.
In addition, Title I of the MMA
authorized the Secretary and the
Administrator of CMS (by delegation) to
establish the Medicare prescription drug
benefit. The drug benefit allows
beneficiaries to obtain qualified
prescription drug coverage. In order to
effectively administer the MA program
and the Medicare prescription drug
benefit, we have substantial
responsibilities to provide information
to Medicare beneficiaries about the
range of health plan options and
benefits available, and to develop better
tools to evaluate these plans and
benefits.
The Affordable Care Act (Patient
Protection and Affordable Care Act,
Pub. L. 111–148, and Health Care and
Education Reconciliation Act of 2010,
Pub. L. 111–152) expanded the
availability of other options for health
care coverage and enacted a number of
changes to Medicare as well as to
Medicaid and the Children’s Health
Insurance Program (CHIP). Qualified
individuals and qualified employers are
now able to purchase private health
insurance coverage through a
competitive marketplace, called an
Affordable Insurance Exchange (also
called Health Insurance MarketplaceSM
or MarketplaceSM). In order to
effectively implement and administer
these changes, we must provide
information to consumers, providers,
and other stakeholders through
education and outreach programs
regarding how existing programs will
change and the expanded range of
health coverage options available,
including private health insurance
coverage through the MarketplaceSM.
The Panel allows us to consider a broad
range of views and information from
interested audiences in connection with
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
this effort and to identify opportunities
to enhance the effectiveness of
education strategies concerning the
Affordable Care Act.
The scope of this panel also includes
advising on issues pertaining to the
education of providers and stakeholders
with respect to the Affordable Care Act
and certain provisions of the Health
Information Technology for Economic
and Clinical Health (HITECH) Act
enacted as part of the American
Recovery and Reinvestment Act of 2009
(ARRA).
On January 21, 2011, the Panel’s
charter was renewed and the Panel was
renamed the Advisory Panel for
Outreach and Education. The Panel’s
charter was most recently renewed on
January 21, 2017, and will terminate on
January 21, 2019 unless renewed by
appropriate action.
Under the current charter, the APOE
will advise the Secretary and the
Administrator on optimal strategies for
the following:
• Developing and implementing
education and outreach programs for
individuals enrolled in, or eligible for,
Medicare, Medicaid, and the Children’s
Health Insurance Program (CHIP), or
coverage available through the Health
Insurance MarketplaceSM.
• Enhancing the federal government’s
effectiveness in informing Health
Insurance MarketplaceSM, Medicare,
Medicaid, and CHIP consumers, issuers,
providers, and stakeholders, through
education and outreach programs, on
issues regarding these programs,
including the appropriate use of publicprivate partnerships to leverage the
resources of the private sector in
educating beneficiaries, providers, and
stakeholders.
• Expanding outreach to vulnerable
and underserved communities,
including racial and ethnic minorities,
in the context of Health Insurance
MarketplaceSM, Medicare, Medicaid,
and CHIP education programs.
• Assembling and sharing an
information base of ‘‘best practices’’ for
helping consumers evaluate health
coverage options.
• Building and leveraging existing
community infrastructures for
information, counseling, and assistance.
• Drawing the program link between
outreach and education, promoting
consumer understanding of health care
coverage choices, and facilitating
consumer selection/enrollment, which
in turn support the overarching goal of
improved access to quality care,
including prevention services,
envisioned under the Affordable Care
Act.
E:\FR\FM\24FEN1.SGM
24FEN1
Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices
The current members of the Panel are:
Kellan Baker, Associate Director, Center
for American Progress; Robert Blancato,
President, Matz, Blancato & Associates;
Dale Blasier, Professor of Orthopaedic
Surgery, Department of Orthopaedics,
Arkansas Children’s Hospital; Deborah
Britt, Executive Director of Community
& Public Relations, Piedmont Fayette
Hospital; Deena Chisolm, Associate
Professor of Pediatrics & Public Health,
The Ohio State University, Nationwide
Children’s Hospital; Josephine DeLeon,
Director, Anti-Poverty Initiatives,
Catholic Charities of California; Robert
Espinoza, Vice President of Policy,
Paraprofessional Healthcare Institute;
Louise Scherer Knight, Director, The
Sidney Kimmel Comprehensive Cancer
Center at Johns Hopkins; Roanne
Osborne-Gaskin, M.D., Senior Medical
Director, MDWise, Inc.; Cathy Phan,
Outreach and Education Coordinator,
Asian American Health Coalition DBA
HOPE Clinic; Kamilah Pickett,
Litigation Support, Independent
Contractor; Brendan Riley, Outreach
and Enrollment Coordinator, NC
Community Health Center Association;
Alvia Siddiqi, Medicaid Managed Care
Community Network (MCCN) Medical
Director, Advocate Physician Partners,
Carla Smith, Executive Vice President,
Healthcare Information and
Management Systems Society (HIMSS);
Tobin Van Ostern, Vice President and
Co-Founder, Young Invincibles
Advisors; and Paula Villescaz, Senior
Consultant, Assembly Health
Committee, California State Legislature.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
II. Provisions of This Notice
In accordance with section 10(a) of
the FACA, this notice announces a
meeting of the APOE. The agenda for
the March 22, 2017 meeting will include
the following:
• Welcome and listening session with
CMS leadership
• Recap of the previous (September 21,
2016) meeting
• Affordable Care Act initiatives
• An opportunity for public comment
• Meeting summary, review of
recommendations, and next steps
Individuals or organizations that wish
to make a 5-minute oral presentation on
an agenda topic should submit a written
copy of the oral presentation to the DFO
at the address listed in the ADDRESSES
section of this notice by the date listed
in the DATES section of this notice. The
number of oral presentations may be
limited by the time available.
Individuals not wishing to make an oral
presentation may submit written
comments to the DFO at the address
listed in the ADDRESSES section of this
VerDate Sep<11>2014
17:20 Feb 23, 2017
Jkt 241001
notice by the date listed in the DATES
section of this notice.
III. Security, Building, and Parking
Guidelines
This meeting will be held in a federal
government building; therefore, federal
security measures are applicable. The
Real ID Act, enacted in 2005, establishes
minimum standards for the issuance of
state-issued driver’s licenses and
identification (ID) cards. It prohibits
federal agencies from accepting an
official driver’s license or ID card from
a state unless the Department of
Homeland Security determines that the
state meets these standards. Beginning
October 2015, photo IDs (such as a valid
driver’s license) issued by a state or
territory not in compliance with the
Real ID Act will not be accepted as
identification to enter federal buildings.
Visitors from these states/territories will
need to provide alternative proof of
identification (such as a valid passport)
to gain entrance into CMS buildings.
The current list of states from which a
federal agency may accept driver’s
licenses for an official purpose is found
at https://www.dhs.gov/real-idenforcement-brief. We recommend that
confirmed registrants arrive reasonably
early, but no earlier than 45 minutes
prior to the start of the meeting, to allow
additional time to clear security.
Security measures include the
following:
• Presentation of government issued
photographic identification to the
Federal Protective Service or Guard
Service personnel.
• Inspection of vehicle’s interior and
exterior (this includes engine and trunk
inspection) at the entrance to the
grounds. Parking permits and
instructions will be issued after the
vehicle inspection.
• Inspection, via metal detector or
other applicable means, of all persons
entering the building. We note that all
items brought into CMS, whether
personal or for the purpose of
presentation or to support a
presentation, are subject to inspection.
We cannot assume responsibility for
coordinating the receipt, transfer,
transport, storage, set up, safety, or
timely arrival of any personal
belongings or items used for
presentation or to support a
presentation.
Note: Individuals who are not registered in
advance will not be permitted to enter the
building and will be unable to attend the
meeting. The public may not enter the
building earlier than 45 minutes prior to the
convening of the meeting.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
11585
All visitors must be escorted in areas
other than the lower and first floor
levels in the Central Building.
Authority: Sec. 1114(f) of the Social
Security Act (42 U.S.C. 1314(f)), sec. 222 of
the Public Health Service Act (42 U.S.C.
217a), and sec. 10(a) of Pub. L. 92–463 (5
U.S.C. App. 2, sec. 10(a) and 41 CFR 102–3).
Dated: February 16, 2017.
Patrick Conway,
Acting Administrator Centers for Medicare
& Medicaid Services.
[FR Doc. 2017–03598 Filed 2–23–17; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Final Effect of Designation of a Class
of Employees for Addition to the
Special Exposure Cohort
National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention, Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
HHS gives notice concerning
the final effect of the HHS decision to
designate a class of employees from the
Pantex Plant in Amarillo, Texas, as an
addition to the Special Exposure Cohort
(SEC) under the Energy Employees
Occupational Illness Compensation
Program Act of 2000.
FOR FURTHER INFORMATION CONTACT:
Stuart L. Hinnefeld, Director, Division
of Compensation Analysis and Support,
NIOSH, 1090 Tusculum Avenue, MS
C–46, Cincinnati, OH 45226–1938,
Telephone 877–222–7570. Information
requests can also be submitted by email
to DCAS@CDC.GOV.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Authority: 42 U.S.C. 7384q(b). 42 U.S.C.
7384l(14)(C).
On January 4, 2017, as provided for
under 42 U.S.C. 7384l(14)(C), the
Secretary of HHS designated the
following class of employees as an
addition to the SEC:
All employees of the Department of
Energy, its predecessor agencies, and their
contractors and subcontractors who worked
at the Pantex Plant in Amarillo, Texas,
during the period from January 1, 1951,
through December 31, 1957, for a number of
work days aggregating at least 250 work days,
occurring either solely under this
employment or in combination with work
days within the parameters established for
one or more other classes of employees in the
Special Exposure Cohort.
This designation became effective on
February 3, 2017. Therefore, beginning
E:\FR\FM\24FEN1.SGM
24FEN1
Agencies
[Federal Register Volume 82, Number 36 (Friday, February 24, 2017)]
[Notices]
[Pages 11583-11585]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03598]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-7044-N]
Health Insurance Marketplace\SM\, Medicare, Medicaid, and
Children's Health Insurance Programs; Meeting of the Advisory Panel on
Outreach and Education (APOE), March 22, 2017
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces the next meeting of the Advisory Panel
on Outreach and Education (APOE) (the Panel) in accordance with the
Federal Advisory Committee Act. The Panel advises and makes
recommendations to the Secretary of the U.S. Department of Health and
Human Services (HHS) and the Administrator of the Centers for Medicare
& Medicaid Services (CMS) on opportunities to enhance the effectiveness
of consumer education strategies concerning the Health Insurance
Marketplace\SM\,\1\ Medicare, Medicaid, and the Children's Health
Insurance Program (CHIP). This meeting is open to the public.
---------------------------------------------------------------------------
\1\ Health Insurance Marketplace\SM\ and Marketplace\SM\ are
service marks of the U.S. Department of Health & Human Services.
DATES: Meeting Date: Wednesday, March 22, 2017 8:30 a.m. to 4:00 p.m.
eastern daylight time (e.d.t).
Deadline for Meeting Registration, Presentations, Special
Accommodations and Comments: Wednesday, March 8, 2017, 5:00 p.m.,
(e.d.t.).
ADDRESSES: Meeting Location: U.S. Department of Health & Human
Services, Hubert H. Humphrey Building, 200 Independence Avenue SW.,
Room 505A, Conference Room, Washington, DC 20201.
Presentations and Written Comments: Presentations and written
comments
[[Page 11584]]
should be submitted to: Thomas Dudley, Designated Federal Official
(DFO), Office of Communications, Centers for Medicare & Medicaid
Services, 7500 Security Boulevard, Mailstop S1-05-06, Baltimore, MD
21244-1850 or via email at Thomas.Dudley@cms.hhs.gov.
Registration: The meeting is open to the public, but attendance is
limited to the space available. Persons wishing to attend this meeting
must register at the Web site https://www.regonline.com/apoemar2017meeting or by contacting the DFO as listed in the FOR
FURTHER INFORMATION CONTACT section of this notice, by the date listed
in the DATES section of this notice. Individuals requiring sign
language interpretation or other special accommodations should contact
the DFO at the address listed in the ADDRESSES section of this notice
by the date listed in the DATES section of this notice.
FOR FURTHER INFORMATION CONTACT: Thomas Dudley, Designated Federal
Official, Office of Communications, CMS, 7500 Security Boulevard, Mail
Stop S1-05-06, Baltimore, MD 21244-1850, 410-786-1442, email
Thomas.Dudley@cms.hhs.gov. Additional information about the APOE is
available on the Internet at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE.html. Press inquiries are handled through
the CMS Press Office at (202) 690-6145.
SUPPLEMENTARY INFORMATION:
I. Background
The Advisory Panel for Outreach and Education (APOE) (the Panel) is
governed by the provisions of Federal Advisory Committee Act (FACA)
(Pub. L. 92-463), as amended (5 U.S.C. Appendix 2), which sets forth
standards for the formation and use of federal advisory committees. The
Panel is authorized by section 1114(f) of the Social Security Act (42
U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42
U.S.C. 217a) and sec. 10(a) of Public Law 92-463 (5 U.S.C. App. 2, sec.
10(a) and 41 CFR 102-3).
The Secretary of the U.S. Department of Health and Human Services
(HHS) (the Secretary) signed the charter establishing the Citizen's
Advisory Panel on Medicare Education \2\ (the predecessor to the APOE)
on January 21, 1999 (64 FR 7899, February 17, 1999) to advise and make
recommendations to the Secretary and the Administrator of the Centers
for Medicare & Medicaid Services (CMS) on the effective implementation
of national Medicare education programs, including with respect to the
Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997
(Pub. L. 105-33).
---------------------------------------------------------------------------
\2\ We note that the Citizen's Advisory Panel on Medicare
Education is also referred to as the Advisory Panel on Medicare
Education (65 FR 4617). The name was updated in the Second Amended
Charter approved on July 24, 2000.
---------------------------------------------------------------------------
The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108-173)
expanded the existing health plan options and benefits available under
the M+C program and renamed it the Medicare Advantage (MA) program. We
have had substantial responsibilities to provide information to
Medicare beneficiaries about the range of health plan options available
and better tools to evaluate these options. The successful MA program
implementation required CMS to consider the views and policy input from
a variety of private sector constituents and to develop a broad range
of public-private partnerships.
In addition, Title I of the MMA authorized the Secretary and the
Administrator of CMS (by delegation) to establish the Medicare
prescription drug benefit. The drug benefit allows beneficiaries to
obtain qualified prescription drug coverage. In order to effectively
administer the MA program and the Medicare prescription drug benefit,
we have substantial responsibilities to provide information to Medicare
beneficiaries about the range of health plan options and benefits
available, and to develop better tools to evaluate these plans and
benefits.
The Affordable Care Act (Patient Protection and Affordable Care
Act, Pub. L. 111-148, and Health Care and Education Reconciliation Act
of 2010, Pub. L. 111-152) expanded the availability of other options
for health care coverage and enacted a number of changes to Medicare as
well as to Medicaid and the Children's Health Insurance Program (CHIP).
Qualified individuals and qualified employers are now able to purchase
private health insurance coverage through a competitive marketplace,
called an Affordable Insurance Exchange (also called Health Insurance
Marketplace\SM\ or Marketplace\SM\). In order to effectively implement
and administer these changes, we must provide information to consumers,
providers, and other stakeholders through education and outreach
programs regarding how existing programs will change and the expanded
range of health coverage options available, including private health
insurance coverage through the Marketplace\SM\. The Panel allows us to
consider a broad range of views and information from interested
audiences in connection with this effort and to identify opportunities
to enhance the effectiveness of education strategies concerning the
Affordable Care Act.
The scope of this panel also includes advising on issues pertaining
to the education of providers and stakeholders with respect to the
Affordable Care Act and certain provisions of the Health Information
Technology for Economic and Clinical Health (HITECH) Act enacted as
part of the American Recovery and Reinvestment Act of 2009 (ARRA).
On January 21, 2011, the Panel's charter was renewed and the Panel
was renamed the Advisory Panel for Outreach and Education. The Panel's
charter was most recently renewed on January 21, 2017, and will
terminate on January 21, 2019 unless renewed by appropriate action.
Under the current charter, the APOE will advise the Secretary and
the Administrator on optimal strategies for the following:
Developing and implementing education and outreach
programs for individuals enrolled in, or eligible for, Medicare,
Medicaid, and the Children's Health Insurance Program (CHIP), or
coverage available through the Health Insurance Marketplace\SM\.
Enhancing the federal government's effectiveness in
informing Health Insurance Marketplace\SM\, Medicare, Medicaid, and
CHIP consumers, issuers, providers, and stakeholders, through education
and outreach programs, on issues regarding these programs, including
the appropriate use of public-private partnerships to leverage the
resources of the private sector in educating beneficiaries, providers,
and stakeholders.
Expanding outreach to vulnerable and underserved
communities, including racial and ethnic minorities, in the context of
Health Insurance Marketplace\SM\, Medicare, Medicaid, and CHIP
education programs.
Assembling and sharing an information base of ``best
practices'' for helping consumers evaluate health coverage options.
Building and leveraging existing community infrastructures
for information, counseling, and assistance.
Drawing the program link between outreach and education,
promoting consumer understanding of health care coverage choices, and
facilitating consumer selection/enrollment, which in turn support the
overarching goal of improved access to quality care, including
prevention services, envisioned under the Affordable Care Act.
[[Page 11585]]
The current members of the Panel are: Kellan Baker, Associate
Director, Center for American Progress; Robert Blancato, President,
Matz, Blancato & Associates; Dale Blasier, Professor of Orthopaedic
Surgery, Department of Orthopaedics, Arkansas Children's Hospital;
Deborah Britt, Executive Director of Community & Public Relations,
Piedmont Fayette Hospital; Deena Chisolm, Associate Professor of
Pediatrics & Public Health, The Ohio State University, Nationwide
Children's Hospital; Josephine DeLeon, Director, Anti-Poverty
Initiatives, Catholic Charities of California; Robert Espinoza, Vice
President of Policy, Paraprofessional Healthcare Institute; Louise
Scherer Knight, Director, The Sidney Kimmel Comprehensive Cancer Center
at Johns Hopkins; Roanne Osborne-Gaskin, M.D., Senior Medical Director,
MDWise, Inc.; Cathy Phan, Outreach and Education Coordinator, Asian
American Health Coalition DBA HOPE Clinic; Kamilah Pickett, Litigation
Support, Independent Contractor; Brendan Riley, Outreach and Enrollment
Coordinator, NC Community Health Center Association; Alvia Siddiqi,
Medicaid Managed Care Community Network (MCCN) Medical Director,
Advocate Physician Partners, Carla Smith, Executive Vice President,
Healthcare Information and Management Systems Society (HIMSS); Tobin
Van Ostern, Vice President and Co-Founder, Young Invincibles Advisors;
and Paula Villescaz, Senior Consultant, Assembly Health Committee,
California State Legislature.
II. Provisions of This Notice
In accordance with section 10(a) of the FACA, this notice announces
a meeting of the APOE. The agenda for the March 22, 2017 meeting will
include the following:
Welcome and listening session with CMS leadership
Recap of the previous (September 21, 2016) meeting
Affordable Care Act initiatives
An opportunity for public comment
Meeting summary, review of recommendations, and next steps
Individuals or organizations that wish to make a 5-minute oral
presentation on an agenda topic should submit a written copy of the
oral presentation to the DFO at the address listed in the ADDRESSES
section of this notice by the date listed in the DATES section of this
notice. The number of oral presentations may be limited by the time
available. Individuals not wishing to make an oral presentation may
submit written comments to the DFO at the address listed in the
ADDRESSES section of this notice by the date listed in the DATES
section of this notice.
III. Security, Building, and Parking Guidelines
This meeting will be held in a federal government building;
therefore, federal security measures are applicable. The Real ID Act,
enacted in 2005, establishes minimum standards for the issuance of
state-issued driver's licenses and identification (ID) cards. It
prohibits federal agencies from accepting an official driver's license
or ID card from a state unless the Department of Homeland Security
determines that the state meets these standards. Beginning October
2015, photo IDs (such as a valid driver's license) issued by a state or
territory not in compliance with the Real ID Act will not be accepted
as identification to enter federal buildings. Visitors from these
states/territories will need to provide alternative proof of
identification (such as a valid passport) to gain entrance into CMS
buildings. The current list of states from which a federal agency may
accept driver's licenses for an official purpose is found at https://www.dhs.gov/real-id-enforcement-brief. We recommend that confirmed
registrants arrive reasonably early, but no earlier than 45 minutes
prior to the start of the meeting, to allow additional time to clear
security. Security measures include the following:
Presentation of government issued photographic
identification to the Federal Protective Service or Guard Service
personnel.
Inspection of vehicle's interior and exterior (this
includes engine and trunk inspection) at the entrance to the grounds.
Parking permits and instructions will be issued after the vehicle
inspection.
Inspection, via metal detector or other applicable means,
of all persons entering the building. We note that all items brought
into CMS, whether personal or for the purpose of presentation or to
support a presentation, are subject to inspection. We cannot assume
responsibility for coordinating the receipt, transfer, transport,
storage, set up, safety, or timely arrival of any personal belongings
or items used for presentation or to support a presentation.
Note: Individuals who are not registered in advance will not be
permitted to enter the building and will be unable to attend the
meeting. The public may not enter the building earlier than 45
minutes prior to the convening of the meeting.
All visitors must be escorted in areas other than the lower and
first floor levels in the Central Building.
Authority: Sec. 1114(f) of the Social Security Act (42 U.S.C.
1314(f)), sec. 222 of the Public Health Service Act (42 U.S.C.
217a), and sec. 10(a) of Pub. L. 92-463 (5 U.S.C. App. 2, sec. 10(a)
and 41 CFR 102-3).
Dated: February 16, 2017.
Patrick Conway,
Acting Administrator Centers for Medicare & Medicaid Services.
[FR Doc. 2017-03598 Filed 2-23-17; 8:45 am]
BILLING CODE 4120-01-P